Ligand Reports Third Quarter 2016 Financial Results
Go back to Ligand Reports Third Quarter 2016 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 293.99 -9.4 (3.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $303.39 | 52 Week High | $139.79 | |||
| Open | $304.06 | 52 Week Low | $82.07 | |||
| Day High | $308.56 | P/E | 683.70 | |||
| Day Low | $293.69 | EPS | $0.43 | |||
| Volume | 395,577 | |||||

